Rohini Chaudhari

  • Dental Membrane and Bone Graft Substitutes Market Estimated to Record Highest CAGR by 2027

    Transparency Market Research has published a new report on the dental membrane and bone graft substitutes market for the forecast period of 2019 - 2027. According to the report, the global dental membrane and bone graft substitutes market was valued at ~US$ 620 Mn in 2018, and is projected to expand at a CAGR of ~7% during the forecast period.

    Global Dental Membrane and Bone Graft Substitutes Market: Key Findings

    Growth of the global dental membrane and bone graft substitutes market can be attributed to rise in the prevalence of dental illnesses, globally, increase in geriatric population, rise in medical tourism for dental procedures, improvement in government-initiated dental reforms, and increase in the number of dental implant procedures.

    North America dominated the global dental membrane and bone graft substitutes market in 2018, and the trend is anticipated to continue during the forecast period. This can be ascribed to the presence of key players, increase in incidence of dental illnesses, and favorable reimbursement policies in the region. According to the American College of Prosthodontists (ACP), currently, 23 million people in the U.S. are completely edentulous, and another 12 million are edentulous in one arch. This is likely to drive the dental membrane and bone graft substitutes market in the U.S.

    Planning To Lay Down Future Strategy? Request Brochure Of Dental Membrane and Bone Graft Substitutes Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=16340

    Increase in Medical Tourism for Dental Procedures to Drive Market

    The number of people travelling overseas for dental procedures has been increasing over the last few years, owing to the low costs of dental procedures and superior-quality services offered to patients at various medical tourism destinations. Furthermore, the demand for dental bone graft substitutes has been rising as a domino effect, owing to rise in the popularity of medical tourism for dental implant procedures. India is one of the leading medical tourism destinations for dental bone grafting procedures, owing to the low prices and strong presence of a large number of JCI-accredited medical facilities in the country that offer superior-quality services to patients. Moreover, infrastructure in India is equipped with advanced technologies, which makes the country an ideal choice for dental medical tourism.

    To Obtain All-Inclusive Information On Forecast Analysis Of Dental Membrane and Bone Graft Substitutes Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=16340

    Increase in Number of Dental Implant Procedures to Drive Market

    Implant dentistry is considered a highly attractive field, and the demand for implant dentistry among patients across the globe is high. Dental bone graft materials are largely used in dental implant procedures. Thus, increase in dental implant procedures would result in rise in the number of bone graft substitute procedures for dental implant placement and bone support in the near future. The number of dental implant procedures is increasing, due to rise in the prevalence of various dental diseases and injuries. For instance, a large number of individuals aged 65 years or above in the U.S. and Germany are edentulous. This is likely to boost the demand for dental implants in these countries during the forecast period. According to the American Academy of Implant Dentistry (2015), three million people in the U.S. have dental implants, and the number is likely to increase by 500,000 every year in the next few years.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=16340

    Dental Bone Graft Products to Lead Global Market

    In terms of product, the dental bone graft segment is likely to account for a major share of the global dental membrane and bone graft substitutes market. In the dental bone graft segment, the allograft sub-segment dominated the market in 2018. However, the xenograft sub-segment is likely to expand at a higher CAGR during the forecast period. This can be attributed to xenograft being a relatively less-expensive form of allograft, which does not lengthen the healing time and eliminates the need for a second surgical site for bone harvesting.

    Dental Clinics to Dominate Global Market

    In terms of end user, the global dental membrane and bone graft substitutes market has been divided into hospitals, dental clinics, and ambulatory surgical centers. The dental clinics segment held the largest market share in 2018, and the trend is anticipated to continue during the forecast period. Expanding geriatric patient pool and growing number of implant procedures that are leading to a surge in the number of bone graft procedures are expected to drive this segment in the near future. Also, dental clinics are preferred by patients for the treatment of various minor tooth illnesses. In addition, increase in the preference for group practice dental clinics, owing to the presence of specialist dentists and practitioners, contributes to the segment growth.

    Global Dental Membrane and Bone Graft Substitutes Market: Prominent Regions

    In terms of region, the global dental membrane and bone graft substitutes market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global dental membrane and bone graft substitutes market in 2018, followed by Europe. North America accounted for a major share of the global dental membrane and bone graft substitutes market in 2018. This can be attributed to the large patient pool suffering from dental disorders, favorable reimbursement policies, and presence of key players in the region.

    The dental membrane and bone graft substitutes market in Asia Pacific is likely to expand at a comparatively higher CAGR from 2019 to 2027. This can be attributed to increase in the focus of market players on investing in developing countries to expand their business. This, in turn, is expected to offer immense opportunity to the market in these countries in the next few years. For instance, in October 2016, Geistlich Pharma AG established Geistlich Pharma India Pvt. Ltd., a wholly-owned subsidiary and 10th global affiliate of the firm. This strategy has enabled the company to commence its operations in India with its globally recognized products for dental regeneration, i.e. Bio-Oss and Bio-Gide, and expand its customer base.

    Innovative Product Launches and Merger & Acquisition Strategies by Key Players to Drive Market

    The global dental membrane and bone graft substitutes market is consolidated in terms of number of players. Key players operating in the global dental membrane and bone graft substitutes market include Institut Straumann AG, Danaher Corporation (Nobel Biocare Services AG), Geistlich Pharma AG, Zimmer Biomet Holdings, Inc., Integra LifeSciences Holdings Corporation, Dentsply Sirona, Inc., BioHorizons, Inc., NovaBone Products, LLC, Collagen Matrix, Inc., Maxigen Biotech, Inc., and Osteogenics Biomedical.

    These players have adopted various strategies such as product portfolio expansion, investment in research & development, and mergers & acquisitions to establish a strong geographic presence. For instance, Danaher Corporation established its strong presence in the dental membrane and bone graft substitutes market through the acquisition of 100% interest in Implant Direct in 2017 and Nobel Biocare Services AG in 2014. In July 2018, Institut Straumann AG acquired 30% stake in botiss biomaterials, a major provider of oral tissue regeneration products, based in Germany. This investment enabled the firm to strengthen its partnership, gain access to botiss’ technology, and expand its global distribution network of botiss’ products.

    More Trending Reports by Transparency Market Research –

    In-vitro Colorectal Cancer Screening Tests Market –

    https://www.globenewswire.com/news-release/2019/02/21/1739306/0/en/In-vitro-Colorectal-Cancer-Screening-Tests-Market-to-Hit-US-980-6-Mn-by-2026-Owing-to-High-Diagnostic-Accuracy-TMR.html

    Read our Case study at

    https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up


  • Clinical Laboratory Services Market Size will Observe Substantial Growth by 2025

    The presence of large numbers of global players and regional participants vying against one another for strong foothold makes the global clinical laboratory services market increasingly fragmented, finds Transparency Market Research (TMR). Several of these are focusing on bringing advancement in laboratory technologies, mainly by including advanced automation features. TMR notes that a growing number of providers in the global clinical laboratory services strive to offer better services to meet the current variety of end-user needs. Top players intend to get a competitive edge over their rivals by providing clinical laboratory services that can diagnose emerging threats of disease strains. Moreover, focus on capacity addition may be an integral part of robust strategy for players in the global clinical laboratory services market.

    Well-entrenched players in the global clinical laboratory services market include Sonic Healthcare, Eurofins Scientific, Laboratory Corporation of America Holdings, Fresenius Medical Care, and NeoGenomics Laboratories Inc.

    Planning To Lay Down Future Strategy? Request Brochure Of Clinical Laboratory Services Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=414

    The global clinical laboratory services market was worth at a whopping US$208.0 bn in 2016. Expanding at a CAGR of more than 6.0% during 2017–2025, the opportunities in the global clinical laboratory services market are forecast to reach US$361.3 bn by the end of this period

    Of the various types of tests offered, clinical chemistry presently holds the leading share in the global clinical laboratory services market. The segment is anticipated to clock a CAGR of over 6% during 2017–2025. The growth is fueled by rapid advancements in analytical techniques such as mass spectrometry and flow cytometry.

    Regionally, North America is presently dominant revenue contributor and is projected to garner an impressive CAGR during the assessment period. The growth is propelled by rising public and private investments in laboratory infrastructures in the region.

    To Obtain All-Inclusive Information On Forecast Analysis Of Clinical Laboratory Services Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=414

    Rising Incidence of Infectious and Chronic Diseases propels Clinical Laboratory Services Market

    The global clinical laboratory services market is driven by the rising worldwide demand for better diagnostics for a variety of disease types, in order to guide therapeutic decisions for better healthcare outcomes. In various developing and developed nations, the rising demand for cutting-edge diagnostics for infectious and chronic diseases is bolster the growth in the clinical laboratory services market. These disease have grown in prevalence in numerous developing economies over the past few years. Moreover, the rising incidence of lifestyle-driven diseases in various parts of the world is propelling advances in the global clinical laboratory services market.

    In recent years, private laboratories have expanded their footprints, especially in developing countries, which has imparted a marked impetus to the market’s growth. To this end, even governments have increased their spending on laboratory infrastructure.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=414

    The global clinical laboratory services market is witnessing new avenues by technological advances in lab testing. These advances notably pertain to the adoption of high-throughput assays. In addition, providers of clinical laboratory services are also developing customized assays to explore new streams of revenues in the market.

    Application of High-Throughput Assays in Drug Development Programs opens New Avenues

    Having said that, the global clinical laboratory services market also faces some setback. The unmet need of improved diagnostic devices in laboratories and the overall lack of clinical expertise in still developing nations hamper prospects.

    On the other hand, emerging threat of bioterrorism in global healthcare systems is a notable trend creating new, exciting opportunities in the global clinical laboratory services market. Moreover, clinical laboratory infrastructures in various developing regions are witnessing the wave of modernization. The rising awareness about the timely diagnosis of diseases, especially in a rapidly aging population, imparts a momentum to the demand for various clinical laboratory services. The growing application of high-throughput assays in drug development programs expands the potential of the global clinical laboratory services market.

    More Trending Reports by Transparency Market Research –

    Haemostasis Valves Market –

    https://www.prnewswire.com/news-releases/haemostasis-valves-market-promises-a-buoyant-path-to-growth-with-4-5-cagr-during-2019-2027-amidst-rising-cases-of-cancer-transparency-market-research-300998401.html

    Read our Case study at

    https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up


  • Dysphagia Supplements Market Size Estimated to Observe Significant Growth by 2025

    Global Dysphagia Supplements Market: Overview

    The demand within the global market for dysphagia supplements has been rising on account of the rising incidence of digestive disorders. Although dysphagia is not entirely a digestive disorder, it is categorised under the purview of stomach-related problems. Dysphagia, in essence, is the inability to swallow food due to improper chewing. Dysphagia can magnify into a serious problems resulting in weakness, anxiety, and other disorders. Furthermore, the demand for swift and immediate treatment for digestive diseases has also created demand within the global dysphagia supplements market. The presence of a well-performing industry for gastric treatments has aided the growth of the global dysphagia supplements market. Dysphagia most commonly occurs in the geriatric population, but other age groups are also at a risk of suffering. Some of the common symptoms of dysphagia include heartburn, drooling, and regurgitation. The occurrence of these symptoms makes it easy to diagnose dysphagia in individuals. The aforementioned factors vindicate the fact that the global dysphagia supplements market would accumulate voluminous revenues in the years to come.

    Report Overview @

    https://www.transparencymarketresearch.com/dysphagia-supplements-market.html

    The global market for dysphagia supplements can be segmented on the basis of the following parameters: product type, distribution channel, and region. It is extremely important to study the dynamics of the aforementioned segments in order to understand market growth.

    The demand within the global market for dysphagia supplements has been rising on account of the rising incidence of digestive disorders. Although dysphagia is not entirely a digestive disorder, it is categorised under the purview of stomach-related problems. Dysphagia, in essence, is the inability to swallow food due to improper chewing. Dysphagia can magnify into a serious problems resulting in weakness, anxiety, and other disorders. Furthermore, the demand for swift and immediate treatment for digestive diseases has also created demand within the global dysphagia supplements market. The presence of a well-performing industry for gastric treatments has aided the growth of the global dysphagia supplements market. Dysphagia most commonly occurs in the geriatric population, but other age groups are also at a risk of suffering. Some of the common symptoms of dysphagia include heartburn, drooling, and regurgitation. The occurrence of these symptoms makes it easy to diagnose dysphagia in individuals. The aforementioned factors vindicate the fact that the global dysphagia supplements market would accumulate voluminous revenues in the years to come.

    The global market for dysphagia supplements can be segmented on the basis of the following parameters: product type, distribution channel, and region. It is extremely important to study the dynamics of the aforementioned segments in order to understand market growth.

    Planning To Lay Down Future Strategy? Request Brochure Of Dysphagia Supplements Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=64329

    A report added by Transparency Market Research (TMR) on the global dysphagia supplements market is an explanation of the trends and opportunities that have aided market growth. The market for dysphagia supplements endows commendable opportunities for growth, and the report analyses all the parameters of growth. A regional outlook on the global market for dysphagia supplements has also been included in the report. The market vendors in the global dysphagia supplements market have been enlisted in the report.

    To Obtain All-Inclusive Information On Forecast Analysis Of Dysphagia Supplements Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=64329

    Global Dysphagia Supplements Market: Trends and Opportunities

    The global market for dysphagia supplements has been expanding alongside advancements in the field of gastric treatments. The availability of several treatments lines for dysphagia has created a buzz across the global market. Moreover, new investments have trickled down from the healthcare industry into the global dysphagia supplements market. Therefore, it is legit to expect that the global dysphagia supplements market would expand at a stellar pace in the years to come. The revenue index of the global dysphagia supplements market is projected to improve alongside availability of trained medical professional and experts. The availability of dysphagia supplements across retail outlets has played a major role in the growth of the global dysphagia supplements market.

    Global Dysphagia Supplements Market: Market Potential

    The global market for dysphagia supplements endows commendable opportunities for growth. The lucrative nature of the market can be gauged from the availability of dysphagia supplements across hospital and retail pharmacies. Furthermore, the investment dynamics of the global dysphagia supplements market have improved in recent times. Dysphagia can lead to multiple other disorders in the body which makes it integral to swiftly treat it. Henceforth, the cumulative demand within the global dysphagia supplements market would expand at a stellar pace in the years to come.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=64329

    Global Dysphagia Supplements Market: Regional Outlook

    On the basis of geography, the global market for dysphagia supplements can be segmented into North America, Asia Pacific, the Middle East and Africa, Europe, and Latin America. The market for dysphagia supplements in North America is expected to expand due to the importance given on treating digestive disorders across the region.

    Global Dysphagia Supplements Market: Competitive Landscape

    Some of the key vendors in the global dysphagia supplements market are Kent Precision Foods Group, Inc. (Kent Corporation) (U.S.), Nestlé Health Science France, and Abbott Laboratories (U.S.).

    The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

    More Trending Reports by Transparency Market Research –

    Radiopharmaceutical Market -

    https://www.prnewswire.com/news-releases/radiopharmaceutical-market-to-reach-valuation-of-us-5-4-bn-by-2027-transparency-market-research-301018881.html

    Read our Case study at

    https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up


  • Gene Synthesis Market Projected to Witness Vigorous Expansion by 2026

    Global Gene Synthesis Market: Analyst’s Estimations

    The first synthesis of an artificial gene dates back to 1970, achieved by Nobel Prize winner Har Gobind Khorana. The India born MIT professor had showcased that large molecules in cells are constituted with genetic information and can be detected via chemical synthesis of nucleic acids and proteins. In the past half a century since the discovery, the concept of gene synthesis has been harnessed furiously and now has turned into a highly robust as well as flexible molecule engineering tool for chemical DNA synthesis. In the recent past, DNA sequencing, automation, and amplification have become an integral part of clinical research pertaining to life science domains such as neuroscience, cancer biology, antibody engineering, genetics, and biochemistry.

    Report Overview @

    https://www.transparencymarketresearch.com/gene-synthesis-market.html

    As per the findings of this business and commerce report, the demand in the global gene synthesis market will expand at a notable compound annual growth rate during the forecast period of 2018 to 2026. Compiled by an experienced healthcare research professional, the report focuses on representing the commerce of the market for gene synthesis, providing qualitative and quantitative data in terms of US dollar million. Developed by following proven market research methodologies, the report segments the market into smaller aspects, gauges the potential of demand showcased by different regions and countries, and profiles a number of leading players in a featured chapter on the competitive landscape.

    Planning To Lay Down Future Strategy? Request Brochure Of Gene Synthesis Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=43520

    This gene synthesis market report has been prepared to act as a credible business tool for targeted audiences such as pharmaceutical and drug manufacturers, biotechnology companies, chemical and biofuel industries, academic and government research institutes, and venture capitalists and investment banks.

    Global Gene Synthesis Market: Drivers and Restraints

    Increased emphasis on clinical research to understand the biological systems at the core molecular level is anticipated to drive the demand in the gene synthesis market in the near future. The growth of the life science research is also a reflection of recent technological advancements that have led to the creation of well-designed products and services such as microchip based gene synthesis, molecular separation, and protein purification. Moreover, gene synthesis has proven its worth as an efficient and cost-effective alternative to classical cloning and mutagenesis procedures. These reliable and time-efficient solutions are prompting federal funding in the developed countries for numerous academic research projects and driving the market. On the other hand, factors such as cut-throat competition that is enticing price reduction and technical limitations across the production process are expected to curtail the prosperity of gene synthesis market in the near future.

    To Obtain All-Inclusive Information On Forecast Analysis Of Gene Synthesis Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=43520

    Global Gene Synthesis Market: Segments

    Based on product type, the market for gene synthesis can be segmented into gene library synthesis and custom gene synthesis. Application-wise, the market can be bifurcated into research and development including industrial and academic, therapeutics, and diagnostics. End user categorization of the gene synthesis market can be done into contract research organizations, academic and research institutes, and biopharmaceutical companies. Geographically, North America and Europe continue to be the regions that are producing most prominent chunk of the total demand for gene synthesis. However, Asia Pacific is anticipated to turn into a lucrative region in the near future owing to increased investment by governments and private organizations.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=43520

    Global Gene Synthesis Market: Competitive Landscape

    Major companies operating in this market are strategically strengthening their supply chain and expanding across different regions by opening production facilities. There are a number of well-established players in the gene synthesis market, such as Thermo Fisher Scientific, Inc., Genewiz, Eurofins Scientific, ATD Bio Ltd., OriGene Technologies, Inc., Bioneer Corporation, Integrated DNA Technologies, Inc., GenScript Biotech Corporation, and Eurogentec. These leading players focused on purity and are expected to hold onto their consolidated position throughout the aforementioned forecast period of this research report.

    More Trending Reports by Transparency Market Research –

    Burn Injury Treatment Market -

    https://www.prnewswire.com/news-releases/tmr-projects-robust-growth-for-burn-injury-treatment-market-rising-effective-treatment-options-to-drive-5-0-cagr-during-2019-2027--301015170.html

    Read our Case study at

    https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up


  • Infusion Pumps Market to Witness Comprehensive Growth by 2026

    The demand within the global market for infusion pumps has been rising on account of advancements in the domain of healthcare over the past decade, finds Transparency Market Research (TMR). The market players operating in the global market for infusion pumps have been focusing on tying up with health centers and hospitals in order to expand their market share. The vendors are also projected to capitalise on the growth of healthcare centers across the globe over the coming years. The key strategies of the market vendors in the global market for infusion pumps include acquisitions, strategic alliances, and partnership.

    The smaller vendors in the global market for infusion pumps have been following the footsteps of the established firms in order to steer clear of the hindrances. These small vendors have been making robust investments towards the development of high-quality products. The larger market players have attained solidity in the market by continually revamping their business strategies according to the needs and demand of the consumers. Furthermore, the market for infusion pumps is closely related to the healthcare industry which has led the market vendors to stay abreast of the trends that are surfacing in this industry. It is expected that the medium-sized market vendors in the global infusion pumps market would enhance their growth prospects by entering into strategic partnerships with larger players.

    Planning To Lay Down Future Strategy? Request Brochure Of Infusion Pumps Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1601

    The global market for infusion pumps is projected to expand at a moderate CAGR of 5.40% over the period between 2018 and 2026, as predicted by Transparency Market Research (TMR). Furthermore, the global market for infusion pumps is expected to accumulate revenues worth well over US$ 10,000.0 Mn by the end of 2026, rising up from a value of US$ 7,036 Mn in 2017. On the basis of product type, insulin pumps are in great demand across the globe. Based on geography, the demand for insulin pumps in North America is expected to touch new heights in the years to come.

    To Obtain All-Inclusive Information On Forecast Analysis Of Infusion Pumps Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=1601

    Rising Incidence of Chronic Diseases to Propel Demand

    The demand within the global market for infusion pumps has been rising on account of the rising geriatric population across the globe. This trend can be explained by the fact that the elderly people are frequently in need of medications that are often administered intravenously rather than orally. Furthermore, chronic diseases such as cancer, diabetes, and cardiovascular disorders often render patients weak and unable to eat which also calls for the use of infusion pumps. The administration of drugs, dextrose, plasma, and saline fluids into the body is done through the use of infusion pumps, and this also enhances the growth prospects of the global market.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=1601

    High Costs of Ambulatory Implantable Devices to Hamper Growth

    Ambulatory implantable devices incur heavy expenses, and this has become a major restrain in the growth of the global market for infusion pumps. Furthermore, healthcare sectors across a number of underdeveloped regions are still barred from the usage of infusion systems due to the limitations of the healthcare sector in these regions. Despite these factors that could hamper the growth of the global market for infusion pumps, the demand within this market is expected to keep soaring as better medical reimbursement policies are introduced by the governments.

    More Trending Reports by Transparency Market Research –

    Neurostimulation Devices market -

    https://www.prnewswire.com/news-releases/digitization-in-healthcare-industry-the-trend-setter-for-emerging-neurostimulation-devices-market-between-2019-and-2027-tmr-30

    Read our Case study at

    https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up


  • Pulse Oximeter Market Growth Prospects, Trends and Forecast up to 2027

    Global Pulse Oximeter Market: Overview

    As home care captures the imagination of people, mainly for convenience and cost associated reasons, particularly in regions where reimbursement policies are weak, contribute heavily to the demand for global pulse oximeter market. It is also quite pertinent to note here demand for remote monitoring is seeing a rapid rise as continuous monitoring is an expensive task, propelling growth in the pulse oximeter market as spot checking via fingertip variants or handheld oximeters can reduce these costs. For instance, this can cut down on readmission costs, which are quite commonly incurred by patients of COPD. Other critical factors include rise in geriatric population and increase in incidence if chronic diseases.

    Report Overview @

    https://www.transparencymarketresearch.com/pulse-oximeters-market.html

    Owing to these factors, the global pulse oximeter market is expected to char a steady growth curve, owing to a notable CAGR (Compound Annual Growth Rate), generating a slew of opportunities, worth a significant market worth, over the forecast period of 2019 and 2027.

    Planning To Lay Down Future Strategy? Request Brochure Of Pulse Oximeter Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=404

    Global Pulse Oximeter Market: Notable Developments

    The global pulse oximeter market is witnessing a slew of developments which are shaping the way the market would operate over the forecast period and beyond. Some of these are also shaping up the competitive landscape.

    2018: In the August of the year, Xhale Assurance Inc. was acquired by Philips. It is critical because with the acquisition Philips now has its hands on the next-generation sensors that were being developed by Xhale Assurance. It is important to note here that the pulse oximeters they have developed can also be used when the perfusion pressure is low, something the traditional variant lacks in. Thus, with the acquisition Philips gets a better place in the market – both in terms of market standing, and product diversification.

    The global pulse oximeter market is fairly fragmented and players identified as notable include Contec Medical Systems Co., Ltd., General Electric Company, Halma plc, Koninklijke Philips N.V., Masimo Corporation, Medtronic plc, Nihon Kohden Corporation, Nonin Medical, Inc., Omron Corporation, and Smiths Group plc, among others.

    To Obtain All-Inclusive Information On Forecast Analysis Of Pulse Oximeter Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=404

    Global Pulse Oximeter Market: Key Trends and Drivers

    Factors driving growth in the global pulse oximeter market are many and varied. Few prominent ones are outlined below:

    • World population is ageing. And, the pace of the process is dizzying. Statistics are grim. One in every six people and one in every four people will be aged 65and above in another 30 years in the world, and in North America and Europe, respectively. Also, people aged 60 and above will see growth in numbers – to 2 billion in 2050, from 900 million in 2015. Already, the world has witnessed history being created in 2018, when the number of geriatrics (aged 65 and above) surpasses the number of children aged five and below. This kind of a demographic shift occurred for the same time in the history of the world. Since, this demographic needs special care and attention, it will lead to more growth in the pulse oximeter market.
    • Incidence of chronic diseases is rising. Of the total disease burden, these account for 73%. In 2002, the burden accounted for by pulse oximeter was 60%. As the incidence remains heavy, and cost of care in hospitals high, demand for pulse oximeter would be high over the forecast period.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=404

    Global Pulse Oximeter Market: Geographical Analysis

    North America is set to dominate the market landscape, owing to a high geriatric population better healthcare system, and presence of an active American Academy of Pediatrics, which endorses the product in a big way. All this together will propel significant growth in the global pulse oximeter market.

    More Trending Reports by Transparency Market Research –

    Legionella Testing Market -

    https://www.globenewswire.com/news-release/2019/03/29/1788547/0/en/Legionella-Testing-Market-to-reach-a-value-of-US-398-7-million-by-2025-TMR.html

    Polypill Products Market –

    https://www.biospace.com/article/polypill-products-market-demand-for-polypill-products-to-scale-new-heights-as-studies-focus-on-reducing-side-effects/


  • Venous Skin Ulcer Treatment Market Demand, Insights and Forecast up to 2030

    Venous Skin Ulcer Treatment Market: Introduction

    According to the report, the global venous skin ulcer treatment market was valued at US$ 2.6 Bn in 2019. It is expected to expand at a CAGR of ~5% during the forecast period from 2020 to 2030. Various advanced technologies and treatment options are presently available for venous skin ulcer. The treatment for skin ulcer include different therapies such as compression therapy, advanced wound dressings, negative pressure wound therapy, and medications. Negative pressure wound therapy involves continuous or intermittent application of sub-atmospheric pressure to the wound dressing system, which provides a positive pressure to the surface of a wound. Some advanced therapies also include skin substitutes, which are tissue engineered skin substitutes made of cells, extracellular matrix, and combination of cells & matrices. These are mostly employed in the treatment of burns, diabetic ulcers, vascular ulcers, and lacerations. North America dominated the global venous skin ulcer treatment market in 2019. It is expected to maintain its dominance, in terms of value, by the end of 2030.

    Planning To Lay Down Future Strategy? Request Brochure Of Venous Skin Ulcer Treatment Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=77547

    Increase in Prevalence & Incidence of Venous Leg Ulcer to Drive Market

    Immobility, varicose veins, obesity, pregnancy, and previous deep vein thrombosis are major factors responsible for the development of venous leg ulcers. Consequently, prevalence and incidence of venous leg ulcers is rising rapidly. Increase in prevalence and incidence of venous leg ulcer is estimated to boost the global venous skin ulcer treatment market. For instance, as per an article published by the National Center For Biotechnology Information (NCBI), the prevalence of venous leg ulcers in the U.S. is around 600,000 annually. The rise in geriatric population and increase in adoption of technologically advanced wound care products are also key factors that drive the global venous skin ulcer treatment market.

    The availability of different skin substitutes and rise in patient awareness and healthcare expenditure are major factors that further propel the global venous skin ulcer treatment market.

    To Obtain All-Inclusive Information On Forecast Analysis Of Venous Skin Ulcer Treatment Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=77547

    Negative Pressure Wound Therapy to be in High Demand

    Based on product, the global venous skin ulcer treatment market has been classified into compression therapy, advanced wound dressings, negative pressure wound therapy, skin grafts & substitutes, medications, and others. The compression therapy segment has been further bifurcated into compression bandages and compression hosiery. The compression therapy segment accounted for a major share of the global venous skin ulcer treatment market in 2019, due to new product launches and higher demand following its features such as better therapeutic effects. Negative pressure wound therapy is a highly promising segment and it is projected to expand at a higher CAGR during the forecast period, owing to rapid healing and decline in the number of dressing changes and risk of pathogenic infection.

    Stage IV Dominated Global Market

    In terms of stage, the global venous skin ulcer treatment market has been segmented into stage I, stage II, stage III, and stage IV. The stage IV segment accounted for a major share of the global venous skin ulcer treatment market in 2019. It is also estimated to expand at a higher CAGR during the forecast period. Long-term management treatment and higher cost of treatment associated with severe form of disease are key factors fueling the stage IV segment.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=77547

    Home Care Settings to be Promising End User

    Based on end user, the global venous skin ulcer treatment market has been divided into hospitals & clinics, long-term care facilities, home care settings, and others. The hospitals & clinics segment has been further split into inpatient settings and outpatient settings. The hospitals & clinics segment held a prominent share of the global venous skin ulcer treatment market in 2019, due to a high number of hospital admissions and better reimbursement facilities provided by hospitals. The home care settings segment is projected to expand at a notable CAGR during the forecast period, owing to an increase in the geriatric population and improvement in healthcare infrastructure and support facilities.

    North America to Lead Global Market

    In terms of region, the global venous skin ulcer treatment market has been divided into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global venous skin ulcer treatment market in 2019, owing to rising prevalence of chronic wounds, better reimbursement scenario, and early adoption of advanced products in the region. For instance, as per Centers for Disease Control and Prevention (CDC) estimates, around 2.5 million patients suffer from pressure ulcers every year in the U.S. The market in Asia Pacific is estimated to expand at a prominent CAGR during the forecast period, owing to an increase in geriatric population, emergence of strong local manufacturers offering technologically advanced products at lower prices, and a rise in awareness among people about early diagnosis of chronic wounds.

    Competition Landscape

    The global venous skin ulcer treatment market is fragmented in terms of number of players with entry of several emerging new players in the market. Key players in the global market include Smith & Nephew plc., Integra LifeSciences Corporation, Mölnlycke Health Care AB, Cardinal Health, 3M, URGO Medical, Bauerfeind, PAUL HARTMANN AG, and SIGVARIS. Research collaborations, mergers, acquisitions & strategic collaborations, and new product & technology launches in recent years are key strategies adopted by major companies operating in the global venous skin ulcer treatment market.

    More Trending Reports by Transparency Market Research –

    Drug Discovery Outsourcing Market –

    https://www.prnewswire.com/news-releases/drug-discovery-outsourcing-market-to-clock-cagr-of-10--during-2020---2030-penetration-of-contract-research-organizations-keep-asia-pacific-highly-lucrative-market-notes-tmr-301077557.html

    Hemostasis Valves Market –

    https://www.biospace.com/article/hemostasis-valves-market-stakeholders-innovate-on-hemostasis-valves-for-future-therapeutic-catheter-development-projects/


  • Biotherapeutics Cell Line Development Market Size to Expand Significantly by the End of 2030

    Biotherapeutics Cell Line Development Market: Introduction

    According to the report, the global biotherapeutics cell line development market was valued at ~US$ 100 Mn in 2019 and is expected to expand at a CAGR of ~7% during the forecast period. Stable cell lines are widely used in various applications, including biologics production, drug screening, and gene functional studies. These cell lines developments have been gaining significance of late, as many blockbuster drugs include biologics. The process of developing stable cell lines often starts with transfecting selected host cells, typically CHO or HEK 293 cells, with desired plasmids. North America dominated the global biotherapeutics cell line development market in 2019. It is expected to continue its dominance by the end of 2030 in terms of revenue.

    Planning To Lay Down Future Strategy? Request Brochure Of Biotherapeutics Cell Line Development Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=8272

    Rise in Demand for Biotherapeutics to Drive Biotherapeutics Cell Line Development Market

    Blockbuster drugs that have been launched recently primarily contain biopharmaceutical ingredients. The biotherapeutics cell line development market has been expanding, owing to the rise in the demand for these biotherapeutics and biosimilar drugs. For instance, the U.S. FDA approved 12 biologics and 34 small molecules drugs in 2017, while the number increased to 17 biologics and 42 small-molecules new drug approvals in 2018. Increase in geriatric population and prevalence of diseases are key factors driving the global biotherapeutics cell line development market. Government initiatives to boost biotechnology & pharmaceutical sectors and development of advanced technologies to cater to the rising demand for monoclonal antibodies are some of the major factors boosting the global biotherapeutics cell line development market.

    Single Cell Cloning to Dominate Biotherapeutics Cell Line Development Market

    Based on process, the global biotherapeutics cell line development market has been bifurcated into transfection & selection and single cell cloning. The single cell cloning segment is expected to dominate the global biotherapeutics cell line development market during the forecast period, owing to rise in demand for biotherapeutics, increase in adoption of instruments such as FACS & ClonePix, and higher throughput nature of this method. The single cell cloning segment has been further sub-segmented into manual LDC, FACs, ClonePix, and others.

    To Obtain All-Inclusive Information On Forecast Analysis Of Biotherapeutics Cell Line Development Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=8272

    Outsource CLD Option to Offer Lucrative Opportunities

    In terms of CLD option, the global biotherapeutics cell line development market has been divided into in-house, outsource, Do-It-Yourself, and hybrid. The outsource segment accounted for a major share of the market in 2019 and is expected to be a highly promising segment during the forecast period. The increase in demand for outsourced products; cost saving; and rapid delivery of products are some of the major factors driving the outsource segment.

    North America to Dominate Biotherapeutics Cell Line Development Market

    Based on region, the global biotherapeutics cell line development market has been divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America held a significant share of the global biotherapeutics cell line development market in 2019, owing to high funding in new biologic drugs, rise in geriatric population, increase in prevalence of various diseases in developed countries in the region, and growth in government funding for research and development activities. According to the Association of the British Pharmaceutical Industry, around US$ 52 Bn was invested in R&D in the pharmaceutical industry in the U.S. in 2016.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=8272

    The biotherapeutics cell line development market in Asia Pacific is estimated to expand at a faster CAGR than that in other regions, owing to considerable expansion of the biopharmaceutical industry and significant investment by global players to build manufacturing plants in the region.

    Competition Landscape

    The global biotherapeutics cell line development market is fragmented, with a large number of players operating in the market. Key players operating in the global biotherapeutics cell line development market include Merck KGaA, Becton, Dickinson and Company (BD), Danaher Corporation, Boehringer Ingelheim Group, Thermo Fisher Scientific, Inc., Lonza Group Ltd., Probiogen AG, Solentim Ltd., Selexis SA, and Sysmex Corporation. Mergers, acquisitions, strategic collaborations, and new product & technology launches are some of the major strategies adopted by prominent companies operating in the global biotherapeutics cell line development market.

    More Trending Reports by Transparency Market Research –

    Video Telemedicine Market –

    https://www.prnewswire.com/news-releases/hipaa-complaint-video-consultations-gain-patient-acceptance-video-telemedicine-market-to-garner-cagr-of-13-during-2020--2030-finds-tmr-301072555.html

    Gonorrhea Therapeutics Market –

    https://www.biospace.com/article/gonorrhea-therapeutics-market-high-scope-of-advancement-with-curative-approach/


  • Theranostics Market Projected to Gain Significant Value by 2027

    Global Theranostics Market: An Overview

    Theranostics is a new field of medicine which relies on targeted therapies to conduct specific targeted tests. These tests are mainly used for various forms of cancers. The key concern in the therapeutics involve patient centric care with the help of more personalised and precise approach. The technique relies on the use of diagnostic and therapeutic applications to form a single agent. The system is known to improve drug delivery, diagnosis, and treatment response monitoring which are key benefits for end-users. The growing incidences of cancers, and increasing need for a combination of therapies for cancers are expected to drive considerable growth for the theranostics market in the near future.

    Report Overview @

    https://www.transparencymarketresearch.com/theranostics-market.html

    Theranostics Market: Notable Developments

    The FDA has approved Mayo Clinic’s new facility in Florida. The facility aims to provide positron emission tomography radiochemistry. The facility plans on conducting various tests include FDA-approved radiotracers and new research. The facility will also conduct various theranostics which are expected to aid help patients with metastatic neuroendocrine tumours. Currently, the facility offers a multispecialty approach which will provide the therapy to over a hundred patients in 2019. The therapy received FDA approval in 2018 and promises a boon for patients with metastatic prostate cancer.

    Planning To Lay Down Future Strategy? Request Brochure Of Theranostics Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=790

    Nihon Medi-Physis or NMP, the largest radiopharmaceutical company in Japan announced an investment JPY3.3Billion for a new research facility catering to theranostics. The program is expected to accelerate processes to establish theranostics*1 or diagnostics. The NMP center promises to utilize a combination of image/therapy regimes using common molecules. Using antibodies or Peptide, the center promises to advance drug delivery system for cancer patients.

    Theranostics Market: Drivers and Restraints

    The theranostics market is expected to drive robust growth as cancer incidences continue to rise and side-effects of procedures like chemotherapy continue to prove challenging for clinicians. Moreover, post-cancer treatment also promises lucrative growth as recovery is often slow and takes considerable time away from patients to get back to normal routines. The growth of various cancers like brain, kidney, liver, breast among others promises several opportunities for players in the theranostics market. Additionally, growing research and development and promising approvals in the FDA pipeline are also expected to remain key drivers of growth in the theranostics market.

    To Obtain All-Inclusive Information On Forecast Analysis Of Theranostics Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=790

    High costs of therapy and their still experimental nature are expected to remain major barriers to growth. Additionally, in regions like North America, healthcare costs and lack of awareness about post-cancer treatments are expected to remain challenges. However, rising awareness are expected to create new opportunities for players in the theranostics market.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=790

    Theranostics Market: Geographical Analysis

    Theranostics market in North America region is expected to register notable growth in the near future. The rising cases of cancers, growing awareness, and expanding care options are expected to remain main drivers of growth in the theranostics market. The theranostics market in Asia Pacific is also expected to witness considerable growth as rising disposable income, large population, and increasing access to healthcare are expected to drive considerable growth in the near future. Rising elderly population, technologically advanced healthcare systems, and options like universal care are expected to drive significant growth in Europe region as well.

    More Trending Reports by Transparency Market Research –

    Medical Cannabis Market –

    https://www.prnewswire.com/news-releases/increasing-legislative-and-legal-amendments-to-help-drive-global-medical-cannabis-market-growth-to-valuation-of-worth-us53-bn-by-2027-finds-tmr-301069367.html

    Controlled Substance Market –

    https://www.biospace.com/article/controlled-substance-market-pain-management-increases-scope-of-opioid-treatment-for-advanced-cancer-patients/


  • Video Telemedicine Market to Flourish with an Impressive CAGR by 2030

    Video Telemedicine Market: Introduction

    According to the report, the global video telemedicine market was valued at ~US$ 1 Bn in 2019 and is projected to expand at a CAGR of ~13% from 2020 to 2030. Video telemedicine is not a distant possibility in emerging economies. Rise in awareness and initiatives by various governments, healthcare associations, and organizations have encouraged healthcare facilities to setup video telemedicine solutions and offer services to patients, especially in remote areas. The application of video telemedicine in various medical procedures such as cardiology, oncology, gynecology, dermatology, neurology, radiology, and orthopedics is propelling the global market.

    Chronic health conditions create a burden on health system in a country. Managing these conditions becomes difficult due to ill-equipped healthcare facilities and lack of experienced workforce. The prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases is rising in developing countries, where there is significant demand for technologically advanced platforms. Video telemedicine makes a doctor available to customers in case of emergencies for managing chronic health conditions. Therefore, video telemedicine is an effective way to address increase in incidence and prevalence of various illnesses.

    Planning To Lay Down Future Strategy? Request Brochure Of Video Telemedicine Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=536

    Advancements in Mobile Penetration, Connectivity, and ICT Services to Drive Video Telemedicine Market

    The mobile connectivity is becoming ubiquitous across the world. Developed markets, such as South Korea, Australia, the U.S., the U.K., Germany, Sweden, and Japan already have penetration of mobile connectivity greater than 100%. Moreover, increase in penetration of smartphones as well as 3G, 4G, and 5G networks is projected to significantly boost the use of mobile platform for providing healthcare services. The video telemedicine market in developing countries is anticipated to grow at a rapid pace during the forecast period driven by advancements in technology. According to the UN Telecommunication Union’s annual report titled, “Measuring the Information Society 2011,” the Republic of Korea is ranked the world’s most advanced ICT economy, followed by Sweden, Iceland, Denmark, and Finland.

    Asymmetric Digital Subscriber Line & Integrated Services Digital Network to Dominate Market

    In terms of communication technology, the global video telemedicine market has been categorized into 3G, 4G, 5G, asymmetric digital subscriber line (ADSL), integrated services digital network (ISDN), and satellite communication. Wired networks form a major portion of the communication base for video telemedicine globally due to large-scale deployment of ADSL and ISDN connectivity. Being a technology-based medical solution, companies need to constantly update their video telemedicine products and services to remain competitive in the market.

    To Obtain All-Inclusive Information On Forecast Analysis Of Video Telemedicine Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=536

    Services to Offer Lucrative Opportunities

    Based on component, the global video telemedicine market has been classified into hardware, software, and services. Video telemedicine systems are expensive and incur significant cost in the deployment and installation of relevant IT infrastructure. Being a technology driven market, companies need to innovate in order to sustain in the market. Therefore, companies are adopting different strategies such as collaboration with system integrators or development and commercialization of a novel video telemedicine solution that reduces cost and improves image quality. Companies are introducing integrative video telemedicine software that eliminates the need for a standalone system or video conferencing room. Furthermore, streamlining of processes besides the usual strategic actions planned for the company’s growth will aid companies to reduce commercialization cost.

    North America to Lead Global Market

    The global video telemedicine market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global video telemedicine market in 2019, followed by Europe. North America accounted for major share of the global video telemedicine market in 2019. This can be attributed to rapid development and adoption of telecommunication technologies, government support in establishing a setup involving usage of new medical technologies for the benefit of people, and favorable reimbursement policies. Moreover, advent of new integrated solutions eliminating the use of standalone video telemedicine devices is expected to drive the market in North America. This solution will lead to a decrease in revenue for video telemedicine device manufacturers globally.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=536

    Competition Landscape

    The global video telemedicine market is fragmented, with the presence of large number of players. Key players in the global market include American Well, Siemens Healthcare GmbH, GlobalMed, Inc., Amwell, Huawei Technologies Co. Ltd., VSee Lab, Inc., Cisco Systems, Inc., Vidyo, Inc., Teladoc, Inc., and Lifesize, Inc. New product development through robust R&D and mergers & acquisitions are key strategies adopted by these players to strengthen presence in the global video telemedicine market.

    More Trending Reports by Transparency Market Research –

    Medical Nonwoven Disposables Market –

    https://www.prnewswire.co.uk/news-releases/medical-nonwoven-disposables-play-crucial-role-in-preventing-spread-of-covid-19-across-countries-continuing-demand-propel-growth-observes-tmr-864325029.html

    Companion Animal Diagnostics Market –

    https://www.biospace.com/article/companion-animal-diagnostics-market-in-house-disease-testing-of-pets-to-gain-popularity/


  • Single-use Bioprocessing Systems Market Size will Observe Substantial Growth by 2028

    Transparency Market Research (TMR) has published a new report titled, “Single-use Bioprocessing Systems Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020–2028”. According to the report, the global single-use bioprocessing systems market was valued at US$ 3.38 Bn in 2019 and is projected to expand at a CAGR of 11.5% from 2020 to 2028.

    Overview

    • The single-use bioprocessing systems market has progressed from being in a nascent phase in the 90’s to a thriving market in recent years due to quicker adoption rates and demand from large as well as smaller niche biopharmaceutical companies. CRO’s and CMO’s which have smaller facility design and operate under stringent deadlines for their customers, are also expected to show significant demand for single-use systems during the forecast period.
    • This demand for single-use bioprocessing systems, particularly bioprocessing bags, single-use filters, and bioreactors has been driven by increase in incidence of hospital acquired infection and high number of adult population.
    • Growth of the global single-use bioprocessing systems market can be attributed to technological advancements & innovation in product offerings and increasing demand for biopharmaceuticals and outsourcing of products
    • Europe dominated the global single-use bioprocessing systems market in 2019, and the trend is anticipated to continue during the forecast period. Highly structured health care industry, early new product adoption, and presence of major players are expected to drive the market in Europe.
    • Asia Pacific is likely to be a highly lucrative market for single-use bioprocessing system, expanding at a high CAGR during the forecast period

    Planning To Lay Down Future Strategy? Request Brochure Of Single-use Bioprocessing Systems Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3753

    Increase in Preference from Biopharmaceutical Organizations and Technological Advancements to Drive Market

    • Single-use bioprocessing systems permit biopharmaceutical organizations to conduct speedy R&D and pilot studies, with the added benefit of lowered capital costs. The prominence of single-use technologies has been higher in the R&D cycle of drug development; however, it is gradually moving from a dormant to nascent growth stage in cGMP production of biologics. Such factors are responsible for driving the market.
    • Advancements in techniques in disposable equipment, products, and consumables have led to increase in sales in the biopharmaceutical industry. New innovative techniques help increase productivity, efficiency, and safety for the users as well as manufacturers.

    Bags Segment to Dominate Market

    • Based on product, the global single-use bioprocessing systems market has been divided into bioreactors & fermenters, mixers, bags, bioprocess containers, filtration devices, tubing, sampling systems, connectors & clamps, and probes & sensors. The bags segment dominated the global single-use bioprocessing systems market in 2019 and the trend is projected to continue during the forecast period. Single-use bags are the most widely used consumables in single-use bioprocessing, owing to their applicability for use in several upstream and downstream bioprocesses such as fermentation, mixing, and sampling. Furthermore, bags are used for storage and transport in addition to bioprocessing functions. Thus, bags are clearly omnipresent throughout the process chain and their disposable nature makes them a vital repeat purchase, resulting in them being a top selling product in this market.

    To Obtain All-Inclusive Information On Forecast Analysis Of Single-use Bioprocessing Systems Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=3753

    Monoclonal Antibody Production Segment to be Highly Lucrative Segment

    • In terms of application, the global single-use bioprocessing systems market has been classified into monoclonal antibody production, vaccine production, plant cell cultivation, patient specific cell therapies, and others
    • Monoclonal antibody production is driven by recent rise in number of monoclonal antibodies in clinical trial stages. The segment is also fueled by recent U.S. FDA and EU approvals for monoclonal antibodies. Both Europe and the U.S. approved approximately 10 antibody therapeutics in 2019, which has resulted in the prominent market share of the segment.
    • Vaccine production is projected to be a highly lucrative segment during the forecast period. Elimination of concerns about cross-contamination and quicker production set-up for vaccine manufacture, especially in case of outbreaks, are the major drivers of the segment.

    Pharmaceutical Companies Segment Accounted for Major Share of Global Market

    • In terms of end-user, the global single-use bioprocessing systems market has been categorized into pharmaceutical companies, biotechnology companies, CROs & CMOs, and academic & research institutes
    • The pharmaceutical companies segment dominated the global single-use bioprocessing systems market in terms of revenue in 2019. The trend is expected to continue during the forecast period. Pharmaceutical companies are embracing single-use technologies, especially for their newly opened biologics facilities. These organizations manufacture multitude products, and thus the adoption of single-use technologies for a few of them helps manage time and cost to introduce the medicines to the market.
    • Biotechnology companies is projected to be a lucrative segment of the global single-use bioprocessing systems market during the forecast period. The segment is anticipated to expand at a significant CAGR from 2020 to 2028. Increase in use of single-use bioprocessing systems in biotechnology companies is expected to drive the segment.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=3753

    Europe to Dominate Global Market

    • In terms of region, the global single-use bioprocessing systems market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Europe dominated the global single-use bioprocessing systems market in 2019, followed by North America.
    • Europe accounted for major share of the global single-use bioprocessing systems market in 2019, owing to CRO’s & CMO’s, niche biotechnology, and multiproduct biopharmaceutical organizations in this region that have been early adopters of single-use technologies compared to their counterparts in the emerging markets
    • The single-use bioprocessing systems market in Asia Pacific is anticipated to expand at a high CAGR from 2020 to 2028. This can be attributed to increase in demand for cost-effective single-use bioprocessing systems and increase in use of single-use bioprocessing systems in pharmaceutical and biotechnology industry in the region. Other prominent countries in single-use bioprocessing systems market in Asia Pacific include South Korea, India, Taiwan, and countries in Southeast Asia.

    Competitive Landscape

    • The global single-use bioprocessing systems market is fragmented in terms of number of players. Key players in the global market include Danaher Corporation, Eppendorf AG, Meissner Filtration Products, Inc., Parker Hannifin Corporation, PBS Biotech, Inc., Thermo Fisher Scientific, Inc., GE Healthcare (General Electric Company), Merck KGaA, Saint-Gobain, and Sartorius AG.

    More Trending Reports by Transparency Market Research –

    Veterinary Radiography System Market –

    http://www.prnewswire.com/news-releases/animal-health-gains-prominence-as-role-shifts-from-pets-to-companions-contributing-to-growth-in-veterinary-radiography-system-market-notes-tmr-301022155.html

    Clinical Laboratory Services Market –

    https://www.biospace.com/article/clinical-laboratory-services-market-increase-in-geriatric-population-to-lead-to-growth-in-clinical-laboratory-services-market/


  • Ventilator Market Growth Analysis up to 2027

    Homecare Ventilator Market: Introduction

    A ventilator is a device that supports breathing. Ventilators assist in getting oxygen into the lungs and removal of carbon dioxide from the body. They help in easy breathing, especially to the people who have lost their ability to breathe. They can partially support in breathing or can control breathing entirely. Depending upon a patient’s condition, a ventilator can help support or completely control breathing.

    Report Overview @

    https://www.transparencymarketresearch.com/homecare-ventilator-market.html

    Global Homecare Ventilator Market: Competitive Landscape

    Key players operating in the global homecare ventilator market include Fisher & Paykel Healthcare Corp. Ltd., Philips Healthcare, Medtronic Plc, ResMed Inc., and Vyaire Medical Inc. The market is much consolidated with the presence of less number of manufacturers. Increase in strategic collaborations and new product launches are expected to drive the global market during the forecast period.

    Planning To Lay Down Future Strategy? Request Brochure Of Ventilator Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=71373

    Medtronic Plc

    Medtronic plc. is a prominent global company that offers medical technology, services, and solutions. Medtronic operates through four segments: Cardiac & Vascular Group, Diabetes Group, Restorative Therapies, and Minimally Invasive Therapies. The company’s segments cater to hospitals, physicians, clinicians, and patients in approximately 160 countries.

    Philips Healthcare

    Philips Healthcare is a subsidiary of Koninklijke Philips N.V., commonly known as Royal Philips.

    Philips Healthcare operates through four divisions: Diagnostic Imaging Systems, Home Healthcare, Customer Services, and Patient Care & Clinical Informatics. The company focuses on complete cycle of care, i.e., disease prevention through screening, diagnosis, and monitoring; and health management. Philips Healthcare has presence in around 100 countries with 450+ products across the world.

    To Obtain All-Inclusive Information On Forecast Analysis Of Ventilator Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=71373

    Global Homecare ventilator Market: Dynamics

    The global homecare ventilator market is driven by various factors at regional, national, as well as global level. Increasing prevalence of respiratory diseases and growing preference to home health care ventilators are major factors contributing to the growth of the global market. Furthermore, increase in investment by public and private sectors for the advancement of health care and surge in technological innovations are projected to propel the global market during the forecast period. Moreover, existing market players are deploying advanced techniques and strategies to develop novel processes for manufacturing of technologically enhanced devices for homecare ventilators. This is anticipated to boost the demand for homecare ventilators for diagnosis of diseases during the forecast period. However, less awareness among people, especially in developing regions and lack of skilled professionals are likely to restrain the global market during the forecast period.

    Increase in Prevalence of Respiratory Diseases to Drive the Market

    According to statistics available with the World Health Organization (WHO), chronic respiratory diseases account for over 5 million deaths each year. The quality of air is deteriorating, particularly in countries where the economy is largely dependent on pollution-intensive industries. About 80% of COPD deaths occur in low and middle income countries. This has translated into increase in prevalence of chronic respiratory diseases, and consequently the demand for medical devices used in the treatment of these diseases. A ventilator is one such medical device used in case of loss of airway anatomy due to edema, trauma, burns, and infection; loss of protective airway mechanism due to intoxicants, brain injury, and strokes; inability to oxygenate appropriately; and in case of any expected clinical course.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=71373

    Increasing Preference for Homecare Ventilators to Drive the Market

    The number of patients requiring prolonged homecare ventilation is rapidly increasing. The WHO estimates that 235 million people suffer from asthma across the world. Studies have indicated that patients on ventilator support are no profit centers for hospital administration. This has induced hospitals to move such patients to alternate care settings.

    Home care givers are often faced with providing specialty care to adult and pediatric patients with medically complex needs. The patients require use of ventilator in order to maintain adequate breathing to sustain life. Homecare ventilators have become more efficient, portable, and easy to operate in different care delivery settings. Hence, usage of portable and transport ventilators has become a preferable choice for both hospitals and patients. Furthermore, usage of portable ventilator in home health care reduces a patient’s cost of stay in the hospital and enhances the quality of life and integration with the community.

    More Trending Reports by Transparency Market Research –

    Wheelchairs Market -

    https://www.prnewswire.com/news-releases/wheelchairs-market-to-surpass-a-value-of-us-6-253-6-million-by-2026--says-tmr-300805704.html

    Corneal Topographers Market –

    https://www.biospace.com/article/corneal-topographers-market-convergence-of-corneal-topographers-and-laser-technology-to-unlock-new-growth-prospects/


  • Needle Free Drug Delivery Devices Market to Garner Brimming Revenues by 2023

    Theglobal needle free drug delivery device market is likely to witness significant growth during the course of forecast period from 2018 to 2026. Transparency Market Research (TMR) found that the global needle free drug delivery devices demonstrates fragmented structure, thanks to presence of regional and international players operating in this market. The manufacturers are largely focused toward research and development activities to launch new product and improve the existing one in order to uphold growth in the needle free drug delivery device industry. Also, various manufacturers are majorly investing in the needle free drug delivery devices to attain more market share. The launch of new technology likely to intensify competition among the key players. TMR also observed that some of the companies such as Zogenix Inc., Pharmajet Inc., Antares Pharma Inc., Glide Pharmaceutical Technologies Ltd., and Injex Pharma AG are majorly investing in North America region in order to gain maximum market share.

    The revenue generated by the global needle free drug delivery devices was pegged at US$5.4 bn in 2014 and is projected to touch US$13 bn by the 2023 end. The global needle free drug delivery devices likely to expand at robust 9.90% CAGR during the course of forecast period from 2015 to 2023.

    Planning To Lay Down Future Strategy? Request Brochure Of Needle Free Drug Delivery Devices Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=447

    On the basis of application, Insulin Delivery is likely to be the key segment in the global needle free drug delivery device market. Rising prevalence of diabetes case and changing lifestyle likely to propel growth of this segment in coming years. Geographically, North America dominate the global needle free drug delivery device market due to increasing number of patients in the region. In addition, growing elderly population in Europe likely to spur growth of the needle free drug delivery device market.

    To Obtain All-Inclusive Information On Forecast Analysis Of Needle Free Drug Delivery Devices Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=447

    Rising Case of Chronic Disease to Drive Growth of Needle Free Drug Delivery Devices Market

    The increasing number of chronic disease like AIDS, Dengue, Hepatitis likely to support growth of the global needle free drug delivery device market. Moreover, the needle free drug delivery device are mainly utilized by the diabetes patients to inject insulin in their body. This is expected to be another factor boosting growth of this market. Rising infrastructure progression in healthcare industry expected to spur growth of this market in coming years. Increasing investment by the manufacturers in the developing economies like Asia Pacific expected to contribute to the growth of the global drug delivery devices market.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=447

    The demand for needle free drug delivery likely to grow in the Middle East and Africa and Latin America due to improvement in healthcare sector. This can be another aspect contributing growth in this region in coming years. The increasing demand for preventive measures for needle-stick injuries likely to fuel demand of this market in foreseeable future. Growing demand for regular administration of drug in disease like hepatitis and dengue likely to contribute toward growth of the needle free drug delivery market. Owing to introduction of advanced technology and rising inclination toward self-administration of drug to positively impact growth of this market in foreseeable future. Reduction in healthcare cost and improve immune response of vaccine anticipated to drive growth of the global needle free drug delivery devices market.

    More Trending Reports by Transparency Market Research –

    Personal Mobility Devices Market –

    https://www.prnewswire.co.uk/news-releases/changing-social-ideologies-coupled-with-favorable-reimbursement-policies-to-help-personal-mobility-devices-market-reach-sales-worth-us-18-bn-by-2027-notes-tmr-892423876.html

    Amniotic Membrane Market –

    https://www.biospace.com/article/amniotic-membrane-market-locally-available-amniotic-allografts-increasingly-meeting-needs-of-patients-with-joint-pain/


  • Rapid Infuser Market Key Opportunities and Forecast up to 2024

    Rapid infuser is a procedure/treatment which involves administration of rapid fluid used during surgical procedure. Rapid infuser device is able to deliver the fluid (human body fluid) from slow to rapid continuous flow. Rapid infuser device is prominently used in emergency situations for safe and effective treatment (when patients are admitted with hypovolemic shock or excessive blood loss). There are two prominent types of rapid infuser devices: one is driven by compressor, while the other is connected to hospital wall pressurized outlets.

    Report Overview @

    https://www.transparencymarketresearch.com/rapid-infuser-device-market.html

    Rapid infuser device is mostly used for the following surgical procedures:

    • Anesthesia and intensive care unit
    • Emergency unit
    • Obstetrics and gynecology
    • Urology division

    Planning To Lay Down Future Strategy? Request Brochure Of Rapid Infuser Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20582

    Convenient and most effective way of delivering fluids in short span of time are the major factors deriving the global market. Moreover, use of this device in anesthesia centers have evolved over the years owing to product enhancements and application of information and sensing technology. Manufacturers in this industry are achieving innovation in patient care through integration of enhanced patient monitors, innovative parameters, wireless devices, workflows, and integrated IT solutions. This has enabled clinicians and anesthesiologists to practice and deliver customized services to patients. Manufacturing companies are not only providing technically advanced products, but also value added services such as predictable patient care, access to clinical information, and thus, optimized reimbursement.

    Moreover, rise in incidence of chronic pulmonary diseases is accelerating market growth. According to new estimates by the World Health Organization, COPD is predicted to become the third leading cause of death by 2030. An estimated 64 million people were suffering from COPD in 2004. Moreover, approximately 13.6 million adults were diagnosed with COPD in the U.S. alone. A rise in geriatric population suffering from COPDs and asthma is further expected to accelerate the growth of the rapid infuser devices market. Increase in the number of surgeries demand development of rapid infuser devices. According to the Centers for Disease Control and Prevention (CDC), approximately 51.4 million surgical procedures were performed in the U.S. alone in 2010, which included 1.01 million cardiac catheterizations, 1.1 million endoscopic procedures of the small intestine (with or without biopsy), 499,000 endoscopic procedures of the large intestine (with or without biopsy), 395,000 coronary artery bypass grafts (CABG), 719,000 knee replacements, and 332,000 total hip replacements. It has also revealed that the number would increase in the near future. However, slow adoption rate of rapid infuser devices by hospitals is expected to hamper market growth.

    To Obtain All-Inclusive Information On Forecast Analysis Of Rapid Infuser Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=20582

    Geographically, the global rapid infuser devices market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America contributed to the largest share of market due to growing patient awareness, favorable initiative taken by the federal government and major market players are based in the region. Asia Pacific and Latin America is identified as the emerging region for rapid infuser devices. Manufacturers have taken advantage of the presence of relatively inexpensive skilled labor in these developing regions to set up manufacturing facilities and launch affordable innovative products. Moreover, the improving scenario for availing better health care facilities in countries such as India and China and the burgeoning medical tourism market in Asia is likely to offer immense growth opportunities in the rapid infuser devices market. Therefore, existing players are recommended to invest in emerging economies to increase their market shares.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=20582

    Key players operating in the global rapid infuser devices market include 410 Medical, Inc., Belmont Instrument Corporation, Smisson-Cartledge Biomedical, LLC, and ZOLL Medical Corporation.

    More Trending Reports by Transparency Market Research –

    Dental 3D Printing Market -

    https://www.globenewswire.com/news-release/2019/03/28/1781467/0/en/Dental-3D-Printing-Market-will-be-worth-US-3-427-1-million-by-2025-TMR.html

    Psoriasis Treatment Market –

    https://www.biospace.com/article/psoriasis-treatment-market-predictive-biomarkers-offer-opportunities-in-specialised-medicine/


  • Surgical Mask Market Opportunity Assessment and Forecast up to 2027

    Global Surgical Mask Market: Overview

    The demand within the global market for surgical mask has been rising on account of advancements in the field of medical surgery and diagnosis. Surgical masks are meant to protect doctors and surgeons from harmful infections and pathogens that may get suspended in the surgery room. Furthermore, the patient who is under treatment also needs to be protected from infectious agents that may be discharged by others in the surgery rooms. Hence, the global market for surgical mask is expected to expand at a stellar pace in the years to follow. There have been multiple attempts at manufacturing improved surgical masks, and this has given an impetus to market growth.

    Report Overview @

    http://www.transparencymarketresearch.com/surgical-mask-market.html

    The presence of a seamless healthcare sector, coupled with utmost focus on safer surgical procedures, has given an impetus to the growth of the global surgical mask market. Furthermore, the need maintaining quality standards across the healthcare domain has also built a plethora of opportunities across the globe. Hence, the global market for surgical mask is projected to win voluminous revenues in the years to come. The efforts of medical facilities in equipping medical practitioners and surgeons with the best surgical masks have aided market growth.

    Planning To Lay Down Future Strategy? Request Brochure Of Surgical Mask Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=67823

    The global market for surgical mask can be segmented on the basis of the following parameters: product, distribution channel, and region. On the basis product, the global surgical mask can be segmented into anti-fog surgical mask, basic surgical mask, fluid/splash resistant surgical mask, N95 mask, and others. Amongst these, the market for basic surgical mask has flown in from multiple healthcare facilities. The key distribution channels for surgical masks are drug stores, hospitals and clinics, and online stores.

    Global Surgical Mask Market: Notable Developments

    The global surgical mask market endows key trends pertaining to the competitive landscape in the contemporary times:

    • Several companies such as 3M Company and Cartel Healthcare are making efforts to develop improved surgical masks.
    • A number of manufacturers of surgical masks have introduced biodegradable masks in order to win larger revenues.

    Some of the key vendors operating in the global surgical mask market are Thea-Tex Healthcare (India) Pvt. Ltd., Z Plus Disposable, Medicare Hygiene Limited, Mediblue Health Care Private Limited., Medline Industries Inc., Plasti Surge Industries Pvt. Ltd., and Premium Health Care Disposables Private Limited.

    To Obtain All-Inclusive Information On Forecast Analysis Of Surgical Mask Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=67823

    Global Surgical Mask Market: Growth Drivers

    • Advent of Best Practices within Medicine

    With the advent of new surgical practices in the domain of medicine, the demand for all forms of surgical aids and equipments has increased. This factor has manifested in the growth of the global market for surgical mask in recent times. Furthermore, the presence of dedicated surgical centers within the healthcare center has also given an impetus to the growth of the global surgical mask market.

    • Need for Improved Safety Standards

    The success rate of surgeries largely depends on the level of safety and precautions taken during surgeries. This factor has also created commendable demand within the global surgical mask market in recent times.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=67823

    Global Surgical Mask Market: Regional Outlook

    On the basis of geography, the global surgical mask market has been segmented into North America, Latin America, Asia Pacific, the Middle East and Africa, and Europe. The market for surgical mask in North America has been growing alongside advancements in the field of medical and surgical procedures in the US and Canada.

    The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

    More Trending Reports by Transparency Market Research –

    Proliferative Diabetic Retinopathy Market -

    https://www.globenewswire.com/news-release/2019/03/27/1774077/0/en/Proliferative-Diabetic-Retinopathy-Market-to-Expand-At-9-5-CAGR-from-2017-2026-Due-To-Growing-Prevalence-of-Diabetes-TMR.html

    Sepsis Therapeutics Market –

    https://www.biospace.com/article/sepsis-therapeutics-market-immunometabolism-delivers-insights-on-new-therapeutic-targets/


  • Vital Signs Monitoring Devices Market Size, Analysis and Forecast up to 2027

    Vital Signs Monitoring Systems Market: Introduction

    Transparency Market Research has published a new report titled, “Global Vital Signs Monitoring Systems Market”. According to the report, the global vital signs monitoring systems market was valued at ~US$ 7.4 Bn in 2018 and is projected to expand at a CAGR of ~5% from 2019 to 2027.

    Vital signs are indicators of the body’s ability to maintain homeostasis. Temperature, pulse, blood pressure, and respiration are considered to be vital signs because these are used to measure some of the body’s vital functions and provide information about a patient’s physical well-being. These also help in monitoring or detecting medical problems. Vital signs can be measured in medical emergency, home care settings, and medical settings. Vital signs monitors help to continuously measure multiple vital signs including temperature, ECG, non-invasive blood pressure, and SpO2. Wearable patch and watch are the recent innovations in vital signs monitoring system. Introduction of new products by key players is anticipated to drive the global vital signs monitoring systems market. For instance, in January 2017, Masimo launched the Rad-97 Pulse-CO Oximeter in India. Furthermore, growth of the global vital signs monitoring systems market can be attributed due to increase in number of patients with chronic cardiovascular and respiratory diseases. For instance, prevalence of COPD is increasing in countries such as India and others in Asia Pacific. An article published by Elsevier Ltd. stated that chronic respiratory diseases, COPD and asthma accounted for 10.9%, 8.7%, and 7.9% deaths, respectively, in India in 2016.

    Planning To Lay Down Future Strategy? Request Brochure Of Vital Signs Monitoring Devices Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2283

    North America dominated the global vital signs monitoring systems market in 2018 and the trend is anticipated to continue during the forecast period. Early adoption of technologically advanced products is likely to fuel the growth of the market in the region. The market in Asia Pacific is projected to expand at a strong CAGR from 2019 to 2027 owing to rise in prevalence chronic diseases due to changes in lifestyle and unhealthy diet. An article published in the International Journal of Chronic Obstructive Pulmonary Diseases stated that prevalence of COPD is higher in men than women in China and the estimated diagnosed rate of COPD varies from 23.61% to 30%.

    Easy Availability of Bench-top Products

    In terms of modality, the global vital signs monitoring systems market has been divided into bench-top, handheld, and wearable. The bench-top segment accounted for major share of the global vital signs monitoring systems market in 2018, owing to easy availability of products. The wearable segment accounted for significant share of the market in 2018. It is anticipated to grow at a rapid pace during the forecast period. Innovation in wearable medical technology is expected to drive the segment.

    To Obtain All-Inclusive Information On Forecast Analysis Of Vital Signs Monitoring Devices Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=2283

    High Demand for Connected Devices-based Vital Signs Monitoring Systems

    Based on technology, the global vital signs monitoring systems market has been bifurcated into connected devices and conventional. The connected devices segment dominated the global vital signs monitoring systems market in 2018. In November 2016, Hill-Rom Services, Inc. announced that its subsidiary, Welch Allyn, entered into the connected home monitoring market along with Home Hypertension Program. The conventional segment accounted for significant share of the global vital signs monitoring systems market in 2018. Growth of the segment can be attributed to emergence of telemedicine.

    Consoles to Account for Major Share of Global Market

    In terms of component, the global vital signs monitoring systems market has been segmented into consoles, accessories & consumables, and apps/software. The consoles segment dominated the global vital signs monitoring systems market in 2018. The apps/software segment is likely to grow at a rapid pace during the forecast period owing to rise in use of Internet of Things in healthcare applications.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=2283

    Rise in Prevalence of Cardiovascular Diseases to Fuel Market Growth

    Based on product, the global vital signs monitoring systems market has been divided into cardiovascular, blood pressure monitoring, body temperature, pulse oximetry, capnography, and respiratory rate. The cardiovascular segment has been bifurcated into ECG and heart rate. The cardiovascular segment dominated the global vital signs monitoring systems market in 2018. Rise in prevalence of cardiovascular diseases and reimbursement support for vital signs monitors are the factors projected to drive the segment. The ECG sub-segment accounted for major share of the cardiovascular segment in 2018. The sub-segment is anticipated to grow at a rapid pace during the forecast period. The pulse oximetry segment held significant share of the global vital signs monitoring systems market in 2018. The segment is expected to expand at a moderate CAGR from 2019 to 2027. The FDA approval for pulse oximeters offered by key players is likely to fuel the growth of the segment. In January 2019, Masimo received the FDA clearance for Rad-97 Pulse CO-Oximeter.

    Hospitals to be Major End User

    In terms of end user, the global vital signs monitoring systems market has been segmented into hospitals, home care, ambulatory surgical centers, and others. The hospitals segment dominated the global vital signs monitoring systems market in 2018 and the trend is projected to continue during the forecast period. Rise in rate of hospitalization for chronic diseases is anticipated to drive the segment.

    Vital Signs Monitoring Systems Market: Prominent Regions

    North America accounted for major share of the global vital signs monitoring systems market in 2018. Product launch & approvals and presence of key players are expected to boost the growth of the vital signs monitoring systems market in the region during the forecast period. In January 2018, Koninklijke Philips N.V. launched IntelliVue X3, next generation patient monitoring solution, in the U.S. IntelliVue X3 is a dual purpose monitor and highly portable with intuitive smartphone-style operation. Moreover, rise in prevalence of cardiovascular diseases is anticipated to fuel the growth of the vital signs monitoring systems market in North America. According to Canada Statistics, estimated incidence of high blood pressure is 90%, and hypertension affects almost 1 in 4 adults in Canada. In 2018, an estimated 5,360,000 people had high blood pressure in Canada.

    Europe held the second largest share of the global vital signs monitoring systems market in 2018. Growth of the market in the region is attributed to adoption of integrated technology and rise in prevalence of chronic diseases. In March 2017, Masimo announced the CE Mark for Rad-97 Pulse CO-Oximeter for non-invasive blood pressure measurement. According to the British Lung Foundation, an estimated 8,028,741 people were living with asthma in the U.K. in 2013.

    Asia Pacific held significant share of the global vital signs monitoring systems market in 2018. The market in the region is expected to grow at a rapid pace during the forecast period. Growth of the market in Asia Pacific is attributed to increase in the geriatric population. Moreover, surge in awareness about telemedicine is likely to accelerate the growth of the vital signs monitoring systems market in the region.

    Competitive Landscape

    Key players are expanding their footprint to strengthen their positions in the global vital signs monitoring systems market. For instance, in May 2017, Masimo announced partnership with Midmark Corporation to improve the efficiency and accuracy of vital signs monitors. This enabled the company to increase interaction of health care professionals and patients and enhance the outcomes at the point-of-care. Increase in focus of industry players on investment in developing regions to expand business is expected to augment the global vital signs monitoring systems market in the next few years.

    More Trending Reports by Transparency Market Research –

    Platelet Rich Plasma & Stem Cell Alopecia Treatment Market -

    https://www.globenewswire.com/news-release/2019/03/26/1768442/0/en/Platelet-Rich-Plasma-Stem-Cell-Alopecia-Treatment-Market-to-Reach-US-450-Mn-by-2026-TMR.html

    Sterilization Services Market –

    https://www.biospace.com/article/sterilization-services-market-rise-in-number-of-hospital-acquired-infections-to-increase-demand/


  • Dental Consumables Market to Reap Excessive Revenues by 2027

    Transparency Market Research (TMR) has published a new report titled, ‘Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’. According to the report, the global dental consumables market was valued at US$ 23,718.0 Mn in 2018 and is projected to expand at a CAGR of 5.4% from 2019 to 2027.

    Planning To Lay Down Future Strategy? Request Brochure Of Dental Consumables Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=554

    Overview

    • Dental consumables are assistive dental medical devices that are used in treatment of various dental disorders such as for the treatment of dental impairments, for dental restoration, and dental implant procedures.
    • Dental consumables primarily comprises of dental implants, crowns and bridges, dental biomaterial, orthodontics, endodontics, and periodontics.
    • The rise in global dental tourism induced by low labor costs, low fixed infrastructure costs and minimum government intervention in emerging economies such as India, Hungary and Turkey, has led to the rise in demand for dental consumable products in these nations.
    • The major growth driver for the dental consumables market in developed countries such as the U.S., Australia, the U.K. and Germany; includes introduction of government initiated dental reforms such as The Comprehensive Dental Reform Act, 2012 along with other growth attributors such as global aging population and rise in demand for cosmetic dentistry.
    • Asia Pacific is likely to be a highly lucrative market for dental consumables and it is expected to expand at a high CAGR during the forecast period

    Rise in Dental Tourism Induced by Low Labor Costs to Drive the Market Growth

    • Dental tourism is a collateral service meant to provide patients with cost-effective oral treatments in developing economies such as India, Turkey, and Hungary. It is widely practiced to attract patients from developed economies, who prefer traveling abroad in search of low-cost and high-quality oral treatments.
    • Dental tourism is flourishing due to low labor costs, low fixed costs, and minimum government intervention in the health care industry in developing economies. For example, root canal treatment starts from US$ 550 in the U.S., while it costs only US$ 110 in Turkey, US$ 69 in Hungary, and US$ 60 in India.

    To Obtain All-Inclusive Information On Forecast Analysis Of Dental Consumables Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=554

    Crowns & Bridges Segment Accounted for Significant Market Share

    • In terms of product, the global dental consumables market has been segmented into dental implants, crowns and bridges, dental biomaterials, orthodontics, endodontics, periodontics, retail dental care essentials and others. Crown and bridges market is estimated to be the largest and fastest growing segment during the forecast period.
    • Within the dental crowns and bridges segment, the ceramic fused to metal is the major product to drive the crowns & bridges market. Changing demographics and increase in demand for CAD/CAM for prosthetics are expected to create growth opportunities in the crowns & bridges segment. Various materials used for construction of crowns and bridges include ceramic crowns, ceramic/porcelain fused to metals (PFM), and metal alloys. Ceramic crowns are gaining popularity, as people are more concerned about the esthetic values pertaining to oral hygiene.
    • Dental implants reported to be the second leading segment is assessed to be an emerging trend among people with missing teeth due to accidents, disease, and injuries. Dental implants are mostly made of titanium and zirconium. Over the relatively short history of dental implants, titanium was determined to be the choice material for implant designs. Titanium, when installed correctly, could withstand the workload of the human jaw similarly to the natural tooth.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=554

    North America to Dominate Global Market

    • In terms of region, the global dental consumables market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Europe dominated the global dental consumables market in 2018, followed by North America.
    • One of the key factors attributed to the growth of the dental consumables market in the region is funding of oral health care facilities in major countries. In 2012, a report titled “The State of Oral Health in Europe” indicated that over 50% of the population of Europe was expected to be diagnosed with some of the periodontal diseases, which were relatively higher among people aged above 60 years.
    • The Dental Consumables market in Asia Pacific is anticipated to expand at a high CAGR during the forecast period due to deregulation of dental care services in countries such as India and China is driving the market in the region. Deregulation refers to the removal of any acts or laws by the government in order to promote private participation. This has led to the emergence of new and improved private clinics that offer assured, quality services.

    Competitive Landscape

    • The global dental consumables market is highly fragmented in terms of number of players providing different products. Key players in the global market include 3M Health Care, Danaher Corporation, DENTSPLY Sirona, Henry Schein, Inc., Institut Straumann AG, Ivoclar Vivadent AG, Patterson Companies, Inc., and Zimmer Biomet Holdings, Inc. Expansion of product portfolio through mergers and acquisitions is a key strategy followed by these players.

    More Trending Reports by Transparency Market Research –

    Epilepsy Therapeutics Market –

    https://www.prnewswire.co.uk/news-releases/technological-advancement-to-drive-market-players-propel-growth-in-epilepsy-therapeutics-market-from-2019-to-2027-tmr-817678120.html

    Biological Imaging Reagents Market –

    https://www.biospace.com/article/biological-imaging-reagents-market-incorporating-technology-in-molecular-imaging-to-positively-impact-market/


  • Negative-pressure Wound Therapy (NPWT) Devices Market Estimated to Record Highest CAGR by 2026

    Transparency Market Research (TMR) has published a new report titled, “Global Negative-pressure wound therapy devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global negative-pressure wound therapy devices market was valued at US$ 2,985 Mn in 2017. It is projected to expand at a CAGR of 9.6% from 2018 to 2026. Increase in prevalence of chronic and acute wounds and obesity & diabetes is anticipated to augment the global market between 2018 and 2026.

    NPWT refers to the application of negative-pressure across a wound. The area is sealed with an adhesive film, and the pump delivers a controlled negative-pressure across the wound bed. Negative-pressure wound therapy devices comprise products such as single-use NPWT devices and conventional NPWT devices. Increase in the prevalence of chronic and acute wounds and obesity & diabetes is expected to propel the global market for negative-pressure wound therapy devices. Additionally, favorable reimbursement policies are likely to propel the global negative-pressure wound therapy devices market. However, availability of alternative method is anticipated to restrain the global market. Moreover, the high cost of negative-pressure technique is a major factor restraining the market.

    Planning To Lay Down Future Strategy? Request Brochure Of Negative-pressure Wound Therapy (NPWT) Devices Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1718

    The report offers detailed segmentation of the global negative-pressure wound therapy devices market based on product, application, and end-user. The market has also been segmented based on region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa). Favorable reimbursement policies and increase in prevalence of chronic and acute wounds is likely to drive the global negative-pressure wound therapy devices market.

    Conventional negative-pressure wound therapy devices segment to account for leading share, while single-use Negative-pressure wound therapy devices segment to expand significantly

    In terms of product, the conventional negative-pressure wound therapy devices segment accounted for a leading share of the global market in 2017. It is anticipated to maintain its leading position in the market during the forecast period. Increase in prevalence of obesity & diabetes across the globe is projected to boost the segment during the forecast period. Increase in demand for negative-pressure wound therapy devices, due to inclination toward minimally invasive procedures, is a key factor that is anticipated to drive the market during the forecast period.

    To Obtain All-Inclusive Information On Forecast Analysis Of Negative-pressure Wound Therapy (NPWT) Devices Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=1718

    Emerging technologies in portable negative-pressure wound therapy devices to propel market

    Emerging technologies in negative-pressure wound therapy devices are projected to boost the global negative-pressure wound therapy devices market during the forecast period. NPWT may decrease tissue oxygenation in the wound bed because the foam sponge of NPWT compresses the wound bed under the influence of the applied negative-pressure. The availability of portable and disposable NPWT devices are expected to boost the market. Digital monitoring and display also positively affects the demand of the product leading to the hike in the growth. Remote controlled mechanisms are also innovated which also helps to propel the market growth.

    North America to be highly lucrative negative-pressure wound therapy devices market

    North America has a large number of negative-pressure wound therapy devices approved for the treatment of various chronic and acute wounds through NPWT. In the U.S., significant increase in prevalence of acute and chronic injuries is likely to propel the share held by the region in the global market during the forecast period. Additionally, product launches and approval for negative-pressure wound therapy devices are anticipated to drive the market in the region.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=1718

    Product launches by key players and patent approvals to boost market

    The report also provides profiles of leading players operating in the global negative-pressure wound therapy devices market. These include SMITH AND NEPHEW, KCI (ACELITY), Cardinal Health, PAUL HARTMANN, ConvaTec Inc., DeRoyal, Genadyne Biotechnologies, Inc., Medela, Inc. ATMOS MedizinTechnik GmbH & Co. KG, Talley Group Ltd, and Lohmann & Rauscher. Launch of new products, focus on development of technologically advanced products by companies, and product approvals are expected to drive the global market during the forecast period. In May 2011, SMITH AND NEPHEW launched a new device PICO- single-use NPWT device for wound management in Negative-pressure wound therapy devices system.

    More Trending Reports by Transparency Market Research –

    Veterinary Orthopedic Implants Market –

    http://www.prnewswire.com/news-releases/high-prevalence-of-osteoarthritis-in-pets-underscoring-growth-in-veterinary-orthopedic-implants-market-from-2018-to-2026-tmr-301025379.html

    Electrophysiology Devices Market –

    https://www.biospace.com/article/electrophysiology-devices-market-rising-incidences-of-cardiac-arrhythmias-expected-to-propel-the-market/


  • Pain Management Devices Market Value Projected to Expand by 2023

    The global pain management devices market features an increasingly competitive landscape marked by rising level of competition among its players. A plethora of players in the market are vying for higher stakes. To this end, they are focusing on unveiling various types of pain management devices with novel technologies in order to reap competitive benefits. Several prominent players have been engaged in expanding their portfolio to consolidate their shares in the global pain management devices market. Rising investments on research and development activities is likely to up the intensity of competition in the pain management devices market in the coming years.

    Some of the top players operating in the global pain management devices market are Bio-Medical Research (BMR) Ltd., Halyard Health, Stryker Corp, Baxter International Inc., and Boston Scientific Corp.

    Planning To Lay Down Future Strategy? Request Brochure Of Pain Management Devices Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1143

    The global pain management devices market stood US$3.75 billion in 2016 and is projected to touch a valuation of US$6.28 billion by the end of 2023. This represents a CAGR of 7.6% during the forecast period of 2015–2023.

    Among the various types of products, neurostimulation devices held the leading share in 2015 and is likely to hold its sway throughout the assessment period. The prevalence of high-impact chronic pain conditions such as those by musculoskeletal is expected to bolster the uptake in the next few years.

    Of the key regional markets for pain management devices, North America has been consistently garnering substantial shares over past few years. The regional market for pain management device is anticipated to continue holding prominent shares in the near future, as well. The growth is increasingly fueled by rising incidence sports-related injuries that need pain management devices.

    To Obtain All-Inclusive Information On Forecast Analysis Of Pain Management Devices Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=1143

    Prevalence of Sports-Related Musculoskeletal Injuries offers Robust Boost

    The rising demand for better management technologies among patient populations world over is a key factor driving the pain management devices market. Globally rising opioid epidemic has offered an attractive impetus to the demand for pain management technologies. Rising elderly populations, especially in developing and developed nations, has contributed to the prevalence of chronic pain. This is a notable trend bolstering the demand for pain management devices. In numerous countries, the rising incidence of sports and recreation-related injuries leading to hospitalization is bolstering the demand for pain management devices. In particular, the demand is increasingly receiving solid boost from the prevalence of sports-related musculoskeletal injuries in developed countries.

    The global pain management devices market is likely to get attractive impetus from several government initiatives and favorable regulatory landscape. In developed nations, reimbursements for spinal cord stimulation devices for patient populations have been fueling the market’s growth in developed countries.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=1143

    Demand for Better Pain Management Devices for Neuropathic Pain creates Substantial Prospects

    The advent of novel pain management devices has created new, exciting avenues in the global market. Increasing pace of commercialization of such devices in recent years has catalyzed rapid market’s expansion.

    The global pain management devices market is likely to witness setbacks on account of low level of patient awareness and the high cost of these devices. Moreover, potential side-effects with certain pain management devices have dampened the uptake. The risk of side effects of skin erosion and surgical site infection associated with neurostimulation implants is a case in point.

    Nevertheless, the rising incidence of neuropathic pain world over is making room for several lucrative avenues for medical device manufacturers. They are expanding their pipeline of products. Moreover, the rising awareness about the ill effects of prescription pain killers kindles patients’ interest in technologically-advanced pain management devices.

    More Trending Reports by Transparency Market Research –

    E. coli Testing Market –

    http://www.prnewswire.com/news-releases/frequent-outbreaks-and-antibiotic-resistant-strains-driving-growth-in-e-coli-testing-market-states-tmr-301019737.html

    DNA Test Kits Market -

    https://www.biospace.com/article/dna-test-kits-market-increase-in-demand-for-ancestry-testing-to-drive-market/


  • Technology Spending on Revenue Cycle Management Market

    The global technology spending on revenue cycle management market features an increasingly competitive landscape. Transparency Market Research observes that the entry of several new companies in the market will up the ante for the incumbent players. Fast-paced regulatory framework in the healthcare industries has created new scope for these vendors to explore new revenue streams in the global technology spending on revenue cycle management market.

    In 2015, a majority of share in the global technology spending on revenue cycle management market was held by three players. These companies are Optum Health, Inc., Cerner Corporation, and Allscripts. They have risen to prominence by leveraging the strengths of their distribution channels and engaging in long-term strategic tie-ups.

    Planning To Lay Down Future Strategy? Request Brochure Of Technology Spending on Revenue Cycle Management Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=17597

    The global market for technology spending on revenue cycle management was worth US$28.50 bn in 2015. Rising at CAGR of 6.9% during 2016–2024, the technology spending on revenue cycle management market will attain a worth of US$51.56 bn by the end of this period.

    Based on various deployment types, cloud-based revenue cycle management will attract higher share of technology spending during the forecast period. The gains of lower up-front costs and increasing accessibility of cloud-based solutions underpins the popularity of the deployment model in the global technology spending on revenue cycle management market.

    Regionally, North presently holds the majority of shares in the global technology spending on revenue cycle management market. However, Asia Pacific holds profound potential and is projected to clock the most attractive CAGR of 8.5% during 2016–2024.

    To Obtain All-Inclusive Information On Forecast Analysis Of Technology Spending on Revenue Cycle Management Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=17597

    Providers recoup Patient Service Revenues

    Worldwide drive for technology spending on revenue cycle management market has stemmed from the need for a unified process for managing all clinical and administrative functions across patient care episodes. This helps healthcare organizations in a better utilization of patient service revenues, thereby propelling investments in technology spending on revenue cycle management. The gains garnered are reflected in the integration of data from electronic health record (EHR), medical billing systems, and various disparate health IT systems, thus boosting the market. Moreover, the intensifying need for hassle-free regulatory compliance has spurred technology spending on revenue cycle management market.

    Deployment of solutions by healthcare organizations for monitoring revenue goals is accentuating the technology spending on revenue cycle management market. Moreover, these solutions have been playing important role in patient recovery outcomes. One of the ways this is accomplished is by improving patient payments or enabling providers review insurance claims for streamlining reimbursement, especially in developing nations.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=17597

    Advent of Cloud-Based Revenue Cycle Management Solutions opens New Avenues

    However, the deployment of revenue cycle management solutions still suffers from the inherent complexity of the systems. In many cases, the adoption of these solutions to a disorderly insurance claims processing in some healthcare organizations has further befuddled the process. On the other hand, growing shifts of healthcare industries for value-based reimbursement is a notable factor bolstering technology spending on revenue cycle management systems. The strides in this direction are prominent in developing regions, notably in Asia Pacific.

    The technology spending on revenue cycle management market has gained momentum from the advent of cloud-based solutions to help healthcare providers derive maximum return on investment. Further, rising popularity of healthcare reforms on the lines of value-based care in various regions is creating lucrative frontiers in the global technology spending on revenue cycle management market. The application of cognitive computing solutions paves way for new avenues.

    More Trending Reports by Transparency Market Research –

    Plaque Modification Devices Market –

    http://www.prnewswire.co.uk/news-releases/plaque-modification-devices-market-to-reach-us-2-1-bn-by-2027-tmr-826918739.html

    Electrophysiology Devices Market –

    https://www.biospace.com/article/electrophysiology-devices-market-rising-incidences-of-cardiac-arrhythmias-expected-to-propel-the-market/


connect